| __timestamp | Veracyte, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 40786000 | 7751000 |
| Thursday, January 1, 2015 | 47876000 | 10251000 |
| Friday, January 1, 2016 | 52035000 | 9575000 |
| Sunday, January 1, 2017 | 55348000 | 10912000 |
| Monday, January 1, 2018 | 65276000 | 11049000 |
| Tuesday, January 1, 2019 | 82720000 | 11646000 |
| Wednesday, January 1, 2020 | 89118000 | 13265000 |
| Friday, January 1, 2021 | 181193000 | 25805000 |
| Saturday, January 1, 2022 | 174078000 | 35182000 |
| Sunday, January 1, 2023 | 184232000 | 94999000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, understanding the financial dynamics of companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: Veracyte, Inc. and Viridian Therapeutics, Inc., from 2014 to 2023.
Veracyte, Inc. has shown a remarkable upward trend in SG&A expenses, with a staggering 352% increase over the decade, peaking in 2023. This growth reflects their aggressive expansion and investment in operational capabilities. In contrast, Viridian Therapeutics, Inc. experienced a more modest rise, with a 1,126% increase, indicating a strategic shift in their business model, particularly evident in the last two years.
This financial trajectory highlights the contrasting strategies of these companies, offering insights into their market positioning and future potential.
SG&A Efficiency Analysis: Comparing Regeneron Pharmaceuticals, Inc. and Veracyte, Inc.
Alnylam Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Alnylam Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Sarepta Therapeutics, Inc. vs Veracyte, Inc.: SG&A Expense Trends
Madrigal Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and Veracyte, Inc.
Amneal Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Rhythm Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared
Veracyte, Inc. vs Merus N.V.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ACADIA Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? ImmunityBio, Inc. or Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.